Home
MosaiQMedia
MosaiQ
-
Vasculitis Diagnosis: Microarray Testing with MosaiQ AiPlex® VAS
What is Vasculitis? Vasculitis is a group of autoimmune disorders that cause inflammation of blood vessels, which can lead to organ and tissue damage. These disorders affect vessels of different sizes (small, medium, large) and may involve multiple organs such as kidneys and lungs, as well as the skin. Common forms include ANCA-associated vasculitis (AAV),…
-
Multiplex Microarray Testing for Connective Tissue Diseases
Key Takeaways What makes connective tissue diseases complex? Autoimmune connective tissue diseases (CTDs) are systemic autoimmune disorders affecting joints, muscles and vital organs. CTDs often present with overlapping symptoms, making clinical diagnosis challenging. Globally, autoimmune rheumatic diseases impact over 4% of the population [1][2] with conditions like systemic lupus erythematosus and Sjögren’s syndrome contributing to…
-
Unlock Lab Efficiencies with an AliveDx Evaluation
The global IVD market portfolio and associated technologies are constantly evolving. AliveDx utilizes innovative technology that provides more automation and multiplex testing to drive lab workflow efficiency. Our MosaiQ® and LumiQ® solutions are designed to help transform autoimmune and allergy diagnostics performance in clinical settings, supporting productivity gains, while driving cost efficiency in a laboratory…
-
Multiplexing: Streamline Autoimmune Testing with MosaiQ AiPlex® CTDplus
In the world of autoimmune diagnostics, time and accuracy are everything. Traditional serological testing often involves multiple assays, manual steps, and long turnaround times. AliveDx is changing that with the MosaiQ® AiPlex CTDplus, a fully automated multiplex microarray immunoassay designed to detect 15 autoantibodies in a single run. Why multiplex matters in autoimmune diagnostics Autoimmune…
-
How Machine Learning Is Transforming CTD Diagnosis
In-vitro diagnostics (IVD) is entering a new era, one where artificial intelligence (AI) and multiplexed immunoassays converge to deliver fast, smart and accurate results. At AliveDx, we’re proud to be at the forefront of this transformation with our MosaiQ® and LumiQ® instruments designed to help streamline lab workflows and transform patient care. In one of…
-
Transforming Vasculitis Diagnostics: Multiplex Microarray Solutions for PR3, MPO & GBM Autoantibodies
In–vitro diagnostics (IVD) is undergoing a transformation, driven by automation and a syndromic approach enabled by multiplexing technologies. At AliveDx, we’re proud to lead this evolution with the MosaiQ AiPlex® VAS microarray, a fully automated multiplex immunoassay designed to detect three critical autoantibodies: PR3, MPO, and GBM in a single, streamlined test. These markers…
-
Machine learning classification based on a 15-autoantibody profile by a fully automated multiplex microarray immunoassay for autoimmune CTD diagnosis
Extended serological profiling may improve autoimmuneconnective tissue diseases (CTD) diagnosis.
-
MosaiQ® System Demonstration
Discover MosaiQ: A groundbreaking IVD solution for autoimmune diseases, allergy, and beyond.
